Melanotan I vs Glow Blend
Side-by-side comparison of Melanotan I and Glow Blend: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Melanotan I
Glow Blend
Melanotan I
Melanotan I (afamelanotide) is a linear synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) with the substitution of norleucine at position 4 and D-phenylalanine at position 7. Unlike Melanotan II (which is…
Lowest listed price: $35.00 across 4 listings
Full Melanotan I profileGlow Blend
GHK-Cu + BPC-157 + TB-500 blend for skin and recovery
Lowest listed price: $99.99 across 3 listings
Full Glow Blend profileSide-by-side comparison
| Attribute | Melanotan I | Glow Blend |
|---|---|---|
| Category | Other | Recovery |
| Research Stage | FDA Approved | Preclinical |
| Mechanism of Action | Melanotan I is afamelanotide, i.e. [Nle4, D-Phe7]-alpha-MSH ('NDP-alpha-MSH'), a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone. The Nle4 and D-Phe7 substitutions make it resistant to enzymatic breakdown and roughly 10-100x more potent… | Glow Blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend" mechanism, and no pharmacology study has ever been run on the three together. Each part… |
| Half-Life | Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance. | Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend. |
| Typical Dose Range | 16 mg | Blend - stated per component: GHK-Cu 1000-2000 mcg/day; BPC-157 250-500 mcg/dose; TB-500 2000-2500 mcg/dose. No validated dose exists for the combination (Research Use Only). |
| Dosing Frequency | every_1_to_4_weeks | GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance. |
| Administration | Subcutaneous, Intramuscular | — |
| Side Effects | Generally mild. Commonly reported: transient nausea (usually milder and less frequent than with Melanotan II), facial flushing, headache, fatigue, and skin hyperpigmentation including darkening of existing moles, freckles and nevi. Implant-site reactions occur… | Most reported effects are local: injection-site redness, swelling, itching, bruising or transient pain, plus mild skin sensitivity. GHK-Cu injections can sting, and with prolonged high-dose systemic use there is a theoretical concern for copper accumulation.… |
| Molecular Weight | 1646.85 g/mol (average; molecular formula C78H111N21O19) | — |
| Common Vial Sizes | 5, 10 | — |
Price History
2 data points- Ion Peptide
- Disguised Alpha
Price tracking
Melanotan I: potential benefits
- Increased melanin (eumelanin) production and skin darkening via MC1R activation, with a reduced UV requirement
- FDA-approved photoprotection in erythropoietic protoporphyria (EPP) as the Scenesse 16 mg subcutaneous implant [PMID:26132941]
- Reduced phototoxic pain and improved quality of life in EPP patients in randomized controlled trials [PMID:26132941]
- Tends to produce fewer MC4R-type effects (spontaneous erections, strong libido, marked nausea) than the cyclic Melanotan II - attributable to Melanotan II's greater potency and metabolic stability, not to true MC1R selectivity of Melanotan I
- Investigated in research settings for photoprotection in UV-sensitive populations
Glow Blend: potential benefits
- Improved skin firmness and elasticity - GHK-Cu raised collagen and elastin and improved aged-skin firmness in controlled cosmetic studies [PMID:18644225]
- Reduced appearance of fine lines and photodamage (GHK-Cu cosmetic data) [PMID:18644225]
- Support for wound and connective-tissue repair - GHK-Cu and BPC-157 accelerated healing in animal models [PMID:8836453][PMID:30915550]
- Angiogenesis / improved local blood-vessel formation - a shared mechanism of BPC-157 and the thymosin beta-4 fragment in TB-500 [PMID:20388964][PMID:14500546]
- Faster recovery from tendon, ligament and muscle strain (BPC-157 preclinical data) [PMID:30915550]
- Anti-inflammatory and antioxidant support during recovery (GHK-Cu and thymosin beta-4) [PMID:18644225][PMID:27450738]
- Reported skin 'glow' and quicker soft-tissue recovery - community/anecdotal only, not clinically verified for the blend
Frequently asked
What's the difference between Melanotan I and Glow Blend?
Melanotan I is a other that melanotan i is afamelanotide, i.e. [nle4, d-phe7]-alpha-msh ('ndp-alpha-msh'), a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone. the nle4 and d-phe7…. Glow Blend is a recovery that glow blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend"…. The two differ in mechanism, half-life (Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance. vs Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.), and typical dose range.
Which has the longer half-life, Melanotan I or Glow Blend?
Melanotan I has a half-life of Controlled-release subcutaneous implant (Scenesse): high inter-subject variability; median Tmax ~36 h, mean Cmax ~3.7 ng/mL, apparent terminal half-life ~15 h, with plasma levels measurable to ~96 h post-dose (FDA pharmacokinetics, n=12). Injected/bolus free peptide: peak plasma at ~1-2 h with an elimination half-life of ~30 minutes; the Nle4/D-Phe7 modifications prolong biological (melanogenic) activity well beyond plasma clearance.. Glow Blend has a half-life of Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Melanotan I or Glow Blend?
Lowest listed price on BodyHackGuide: Melanotan I from $35.00, Glow Blend from $99.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack Melanotan I and Glow Blend?
Stacking depends on mechanism overlap, safety profile, and goals. Melanotan I and Glow Blend should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Melanotan I or Glow Blend
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.